Wenjun Guo

Beijing Institute of Technology — China

Medicine · Health Sciences

29h-index18.1kcitations80works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(32), Cell Adhesion Molecules Research(8), Immunotherapy and Immune Responses(6), Cancer Genomics and Diagnostics(6), Autism Spectrum Disorder Research(5)

Publications80 total

Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
Cancer Cell·2025· 2 citedOpen Access
CD169+ macrophages orchestrate anti-tumor CD8+ T cell immunity in a preclinical model of breast cancer 3914
The Journal of Immunology·2025Open Access
Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells
Immunity·2025· 5 citedOpen Access
Metal-organic framework nanomaterials alter cellular metabolism in bladder cancer
Ecotoxicology and Environmental Safety·2025Open Access
Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway
Journal of Ethnopharmacology·2025· 3 cited
Predicting optimal endotracheal tube depth in children based on height and middle finger length
Pediatric Research·2025
Recent advances in composite materials integrating molecularly imprinted polymers for targeted drug delivery systems
European Polymer Journal·2025· 12 cited
Positively charged cytoplasmic residues in corin prevent signal peptidase cleavage and endoplasmic reticulum retention
Communications Biology·2025· 1 citedOpen Access
Sensitivity-Guided Multi-stage Sequential Quadratic Programming for Launch Sequence Optimization
Lecture notes in electrical engineering·2025
Cardiac corin and atrial natriuretic peptide regulate liver glycogen metabolism and glucose homeostasis
Cardiovascular Diabetology·2024· 4 citedOpen Access
MicroRNA-1205 promotes breast cancer cell metastasis by regulating epithelial-to-mesenchymal transition via targeting of CDK3
Cellular Signalling·2024· 2 cited
Abstract 3959: Unraveling the anti-tumor partnership of CD169+ macrophages and CD8+ T cells in a preclinical breast cancer model
Cancer Research·2024
Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance
Science Advances·2023· 23 citedOpen Access
A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression
Developmental Cell·2023· 20 citedOpen Access
Loss of the MLL3 tumor suppressor accelerates breast tumor onset via HIF1a-induced CCL2-mediated recruitment of CCR2+ regulatory T cells
The Journal of Immunology·2023Open Access
Abstract A013: Loss of MLL3 epigenetic regulator drives metastasis by promoting a hybrid epithelial-mesenchymal transition state
Cancer Research·2023
MLL3 loss drives metastasis by promoting a hybrid epithelial–mesenchymal transition state
Nature Cell Biology·2023· 68 citedOpen Access
Abstract B009: A SOX9-B7x axis safeguards dedifferentiated tumor cells from immunosurveillance to enable DCIS progression
Cancer Prevention Research·2022Open Access
The MLL3/TP53/PIK3CA cancer driver mutations promote HIF1α-dependent recruitment and differentiation of pro-tumor ICOS <sup>hi</sup> GITR <sup>hi</sup> Blimp-1 <sup>+</sup> effector regulatory T cells in breast tumors
2022Open Access
Cancer stem cells
˜The œbiomedical & life sciences collection.·2022Open Access
page 1 of 4Next →

Frequent Co-authors

Filippo G. Giancotti(7), John R. Christin(7), Sendurai A. Mani(6), Robert A. Weinberg(6), Maja H. Oktay(6), Zhangyong Hong(6), Ferenc Reinhardt(5), Jihong Cui(5), Elinor Ng Eaton(3), Danwei Huangfu(3), Toshiaki Yoshioka(3), Deyou Zheng(3), Jeffrey E. Segall(3), John S. Condeelis(3), Chunhui Wang(3), Min Yu(3), Cheng Zhang(2), René Maehr(2), Astrid Eijkelenboom(2), Douglas A. Melton(2)